Another study found a 0.83% overall risk of these events in GLP-1 RA users compared to a 0.63% overall risk of these events in non-GLP-1 RA controls (Bloomgarden 2024)
664,665 Given the lack of experience with antithrombotics, antihypertensive agents, and statins for secondary stroke prevention in SCD, specific recommendations cannot be stated outside of general treatment recommendations
A study found that people with higher blood glutathione levels were less likely to develop cataracts or glaucoma, while those with lower levels were at increased risk
Beyond genetics, your starting weight, kidney function, other medications, and gastrointestinal sensitivity all influence optimal dosing
The most important thing to remember is that this change is entirely possible with the right medical guidance and a personalized plan